ARDS Study Using Data and AI
Part of Infections, Lungs & breathing clinical trials.
This study gathers information from patients with or at high risk of acute respiratory distress syndrome (ARDS), a severe lung injury. It aims to create a database and use artificial intelligence to better understand and treat ARDS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in the intensive care unit (ICU).
- You must be 18 years or older.
- You either have ARDS (as defined by the new global criteria) or are at high risk of developing it (like having severe pneumonia, sepsis, or a serious injury).
- You cannot be in another clinical trial right now.
- You must agree to participate by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for patients in the ICU with ARDS (a severe lung condition). It looks at biomarkers (special substances in your blood) to help understand different types of ARDS. You do not receive any treatment, but you help researchers learn more about the disease.
This trial observes the symptoms, treatments, and recovery of patients with acute respiratory distress syndrome (ARDS), a serious lung condition. It aims to learn more about how different types of breathing support affect outcomes.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study examines lung fluid samples and imaging scans from patients on breathing machines to better understand acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers hope this will help doctors diagnose and treat ARDS more effectively in the future.
This study looks at different types of inflammation in patients with Acute Respiratory Distress Syndrome (ARDS), a serious lung condition. It aims to find which treatments work best for each subtype.
This study looks at different patterns in patients with a severe lung condition called ARDS, to better understand why some respond to treatments differently. You may help doctors learn how to personalize care.
Hear when a new Respiratory Distress Syndrome, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.